Polyphenols and cholesterol efflux: Is coffee the next red wine?

Circulation Research

Volumn 106, Issue 4, 2010, Pages 627-629

  Burke, Megan F ^a   Khera, Amit V ^a   Rader, Daniel J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiovascular disease; Coffee; Macrophage cholesterol efflux; Phenolic acids; Polyphenols

Indexed keywords

ANTHOCYANIN; CAFFEIC ACID; CATECHIN; FERULIC ACID; ISOFLAVONE DERIVATIVE; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL;

CHOLESTEROL TRANSPORT; COFFEE; DIETARY INTAKE; EDITORIAL; HUMAN; PRIORITY JOURNAL; RED WINE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BEVERAGES; BIOLOGICAL TRANSPORT; CHOLESTEROL; COFFEE; CORONARY DISEASE; FLAVONOIDS; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; PHENOLS; SCAVENGER RECEPTORS, CLASS B; UP-REGULATION; WINE;

EID: 77949384423     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.215855     Document Type: Editorial

References (27)

1. Ashen MD, Blumenthal RS. Clinical practice. Low HDL cholesterol levels. N Engl J Med. 2005;353:1252-1260.
2. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B, ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357:2109-2122.
3. Rader DJ. Illuminating HDL-is it still a viable therapeutic target? N Engl J Med. 2007;357:2180-2183.
4. deGoma EM, deGoma RL, Rader DJ. Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol. 2008;51: 2199-2211.
5. Cuchel M, Rader DJ. Macrophage RCT: key to the regression of atherosclerosis? Circulation. 2006;113:2548-2555.
6. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. The role of RCT in animals and humans and relationship to atherosclerosis. J Lipid Res. 2009;50(suppl):S189-S194.
7. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem. 2000;275:28240-28245.
8. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA. 2004;10:9774-9779.
9. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, Billheimer JT, Rothblat GH, Rader DJ. Pharmacological activation of liver X receptors promotes RCT in vivo. Circulation. 2006;113:90-97.
10. Katz A, Udata C, Ott E, Hickey L, Burczynski ME, Burghart P, Vest-erqvist O, Meng X. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol. 2009;49:643-649.
11. Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol. 1996;34:119-129.
12. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990;323:1026-1032.
13. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, Speizer FE, Hennekens CH. Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA. 1996;275:458-462.
14. Lopez-Garcia E, van Dam RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, Rexrode KM, Hu FB. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 2006;113:2045-2053.
15. Greenberg JA, Chow G, Ziegelstein RC. Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the framingham study). Am J Cardiol. 2008;102:1502-1508.
16. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295: 1135-1141.
17. Fried RE, Levine DM, Kwiterovich PO, Diamond EL, Wilder LB, Moy TF, PearsonTA. The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial. JAMA. 1992;267:811-815.
18. Scalbert A, Williamson G Dietary intake and bioavailability of poly-phenols. J Nutr. 2000;8S(suppl):2073S-2085S.
19. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavail-ability and bioefficacy of polyphenols in humans. I. Review of 97 bio-availability studies. Am J Clin Nutr. 2005;1(suppl):230S-242S.
20. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16:77-84.
21. Sevov M, Elfineh L, Cavelier LB. Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem Biophys Res Commun. 2006;348:1047-1054.
22. Berrougui H, Grenier G, Loued S, Drouin G, Khalil A. A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxi-dation and enhancement of cholesterol efflux. Atherosclerosis. 2009;207: 420-427.
23. Xia M, Hou M, Zhu H, Ma J, Tang Z, Wang Q, Li Y, Chi D, Yu X, Zhao T, Han P, Xia X, Ling W. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J Biol Chem. 2005;280:36792-36801.
24. Uto-Kondo H, Ayaori M, Ogura M, Nakaya K, Ito M, Suzuki A, Takiguchi SI, Yakushiji E, Terao Y, Ozasa H, Hisada T, Sasaki M, Ohsuzu F, Ikewaki K. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages. Circ Res. 2010; 106:779-787.
25. Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C. Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr. 2007;137:2196-2201.
26. Murphy EJ. Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism. J Anim Sci. 2006;84(suppl): E94-E104.
27. Adorni MP, Zimetti F, Billheimer JT, Wang N, Rader DJ, Phillips MC, Rothblat GH. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res. 2007;48:2453-2462.